Evidence map›Paper›PMID 31060545›Full record

Trial reportBMC public health2019

Hypertension control in integrated HIV and chronic disease clinics in Uganda in the SEARCH study.

Dalsone Kwarisiima, Mucunguzi Atukunda, Asiphas Owaraganise, Gabriel Chamie, Tamara Clark, Jane Kabami, Vivek Jain, Dathan Byonanebye, Florence Mwangwa, Laura B Balzer and 5 more

2 registry-linked trialsOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC public health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 80 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed, 2 pooled it
17.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01864603 nacompletednot on this map

Sustainable East Africa Research in Community Health

TypeinterventionalSponsorUniversity of California, San FranciscoRan2013 to 2021Enrolled150,395ConditionsHIV, Tuberculosis, Hypertension, DiabetesArmsUniversal ART in a streamlined care model, Annual Community Health Campaigns, Targeted PrEP and Targeted testing interventions, Baseline community-based HIV and multi-disease testing
NCT05002322 nacompletednot on this mapstarted 2023, after this paper: background citation

Scaling Out and Scaling Up the Systems Analysis and Improvement Approach to Optimize the Hypertension Diagnosis and Care Cascade for HIV-infected Individuals

TypeinterventionalSponsorEduardo Mondlane UniversityRan2023 to 2025Enrolled18ConditionsHypertensionArmsSystems Analysis and Improvement Approach
3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 2 syntheses or guidelines pooled it, 118 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Dalsone KwarisiimaInfectious Diseases Research Collaboration, Kampala, Uganda.
Mucunguzi AtukundaInfectious Diseases Research Collaboration, Kampala, Uganda.
Asiphas OwaraganiseInfectious Diseases Research Collaboration, Kampala, Uganda.
Gabriel ChamieUniversity of California San Francisco, San Francisco, CA, USA.
Tamara ClarkUniversity of California San Francisco, San Francisco, CA, USA.
Jane KabamiInfectious Diseases Research Collaboration, Kampala, Uganda.
Vivek JainUniversity of California San Francisco, San Francisco, CA, USA.
Dathan ByonanebyeInfectious Diseases Research Collaboration, Kampala, Uganda.
Florence MwangwaInfectious Diseases Research Collaboration, Kampala, Uganda.
Laura B BalzerUniversity of Massachusetts, Amherst, MA, USA.
Edwin CharleboisUniversity of California San Francisco, San Francisco, CA, USA.
Moses R KamyaInfectious Diseases Research Collaboration, Kampala, Uganda.
Maya PetersenUniversity of California, Berkeley, CA, USA.
Diane V HavlirUniversity of California San Francisco, San Francisco, CA, USA.
Lillian B BrownUniversity of California San Francisco, San Francisco, CA, USA. Lillian.Brown@ucsf.edu.ORCID http://orcid.org/0000-0003-1809-3762
Infectious Diseases Research Collaboration · UGUniversity of California, San Francisco · USUniversity of California, Berkeley · USUniversity of Massachusetts Amherst · US

Funding

Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/UM1AI068636 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Joseph J Eron, RAJESH T GANDHI · 2011 to 2026
$1073.1M
Building Implementation Science Capacity at Makerere University to Strengthen the Response to the HIV/AIDS Epidemic in UgandaD43TW010037 · FIC · MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES · PI KAMYA, MOSES ROBERT, SEMITALA, FRED C · 2015 to 2025
$3.3M
FIC NIH HHS D43 TW010037National Institute of Allergy and Infectious Diseases U01A1099959National Institute of Allergy and Infectious Diseases UM1AI068636NIAID NIH HHS UM1 AI068636
6 · The paper itself

Abstract

backgroundThere is an increasing burden of hypertension (HTN) across sub-Saharan Africa where HIV prevalence is the highest in the world, but current care models are inadequate to address the dual epidemics. HIV treatment infrastructure could be leveraged for the care of other chronic diseases, including HTN. However, little data exist on the effectiveness of integrated HIV and chronic disease care delivery systems on blood pressure control over time.

methodsPopulation screening for HIV and HTN, among other diseases, was conducted in ten communities in rural Uganda as part of the SEARCH study (NCT01864603). Individuals with either HIV, HTN, or both were referred to an integrated chronic disease clinic. Based on Uganda treatment guidelines, follow-up visits were scheduled every 4 weeks when blood pressure was uncontrolled, and either every 3 months, or in the case of drug stock-outs more frequently, when blood pressure was controlled. We describe demographic and clinical variables among all patients and used multilevel mixed-effects logistic regression to evaluate predictors of HTN control.

resultsFollowing population screening (2013-2014) of 34,704 adults age ≥ 18 years, 4554 individuals with HTN alone or both HIV and HTN were referred to an integrated chronic disease clinic. Within 1 year 2038 participants with HTN linked to care and contributed 15,653 follow-up visits over 3 years. HTN was controlled at 15% of baseline visits and at 46% (95% CI: 44-48%) of post-baseline follow-up visits. Scheduled visit interval more frequent than clinical indication among patients with controlled HTN was associated with lower HTN control at the subsequent visit (aOR = 0.89; 95% CI 0.79-0.99). Hypertension control at follow-up visits was higher among HIV-infected patients than uninfected patients to have controlled blood pressure at follow-up visits (48% vs 46%; aOR 1.28; 95% CI 0.95-1.71).

conclusionsImproved HTN control was achieved in an integrated HIV and chronic care model. Similar to HIV care, visit frequency determined by drug supply chain rather than clinical indication is associated with worse HTN control.

trial registrationThe SEARCH Trial was prospectively registered with ClinicalTrials.gov : NCT01864603.

Indexed as

Delivery of Health Care, IntegratedAdultAgedChronic DiseaseFemaleHIV InfectionsHumansHypertensionMaleMiddle AgedRural PopulationUgandaHIV/AIDSHypertensionIntegrated careSub-Saharan Africa

Identifiers

PMID31060545
PMCPMC6501396
OpenAlexW2947298741

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.